SHIRE PLC (SHPG) Stock News
NASDAQ:SHPG - Nasdaq - US82481R1068
SHPG Latest News, Press Relases and Analysis
Why Mirum Pharmaceuticals Stock Skyrocketed 44% Today
The company's clinical trial is taking an important step forward.
Mentions: MIRM
The Daily Biotech Pulse: Amgen Slashes Cholesterol Drug Device Prices By 60%, Takeda Completes Shire Purchase
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech Stocks Hitting 52-week highs on Jan. 7) Axsome Therapeutics Inc (...
The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas
Here's a roundup of top developments in the biotech space over the last 24 hours. No biotech stocks hit 52-week highs Tuesday. Down In The Dumps (Biotech stocks hitting 52-...
Dow Futures Drop 248 Points as Big Biotech Deal Overshadowed by Apple Tumble
The market worries that Apple’s reduced guidance is a sign of bigger problems to come in China.
Dow Ready to Rise Because Progress, Progress
President Donald Trump’s tweet that progress was made in a phone call with China’s Xi Jinping has helped boost markets on a quiet New Year’s Eve.
Will Big Pharma's Giant Maw Scoop Up These Small-Cap Players?
Bristol, Lilly and Pfizer will be among a cadre of Big Pharma players "hunting for deals" among small and midsize pharmaceutical companies.
Biotech Buying Spree: Why These 3 Stocks Could Get Deals In 2019
Sarepta, Sage and Loxo are the most likely mergers among biotech stocks in 2019, according to RBC Capital Markets analysts.
Shire, Abbot Labs May Pace Healthcare Stocks in 2019
Healthcare has been the best performing sector of the market this year. Here are three buy-rated stocks to track now.
Takeda Shareholders Vault Another Hurdle To $62 Billion Shire Buyout
Takeda shareholders voted overwhelmingly Wednesday in favor of its Shire acquisition. The pharmaceutical companies say the deal will close Jan. 8.
Mentions: BMY
General Electric Debt Fears Are Overblown, Says Analyst
Credit markets stage a modest comeback, while junk-bond issuers withdraw some offerings and investment-grade issuers sweeten their deals.
Pharma Giant Shire Dips On Mixed Third Quarter, Light Guidance
Shire stock dipped Thursday on the firm's mixed third-quarter report as revenue from eye drugs and internal medicine lagged Wall Street's expectations.
Best And Worst ADRs - Monday, Sept. 24
The best-rated sectors in our ADR universe are healthcare and basic materials.
Shire plc, each representing three Ordinary Shares (SHPG): Product News News
SHPG – Receives approval of Firazyr for the treatment of hereditary angioedema attacks in Japan.